Long-term outcomes of complex medical rehabilitation of patients with rhinosinusitis with nasal polyposis and comorbidities

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Comparative evaluation of courses of alternating magnetic therapy, low-intensity laser therapy, low-intensity laser radiation and hypoxic training in complex medical rehabilitation of atopic dermatitis and asthma patients with rhinosinusitis with nasal polyposis showed high efficacy of the additional use of physical factors in enhancing the regression of major clinical manifestations of the disease and improving the quality of life.

AIM: The aim of the study was to evaluate the long-term (6, 12, and 18 months) outcomes of complex medical rehabilitation of patients with rhinosinusitis with nasal polyposis, including those with atopic dermatitis and asthma, to assess the preventive potential of instrumental physiotherapy, and to determine the optimal time parameters for retreatment with these therapeutic options.

MATERIALS AND METHODS: Patients were divided into groups with isolated rhinosinusitis (n=90), atopic rhinosinusitis (n=93) or asthma (n=105) according to the severity of rhinosinusitis with nasal polyposis. Each group was in turn randomized into 3 subgroups: the control one, the comparator one, and the experimental one. All subjects received a standard treatment program (endonasal Nasonex, 2 doses twice a day; daily nasal rinsing twice a day). Patients in the comparator subgroups also received dupilumab (300 µg once every 2 weeks); the experimental subgroups received alternating magnetic therapy and low-intensity red laser radiation (633 nm). For atopic dermatitis, narrowband medium wave (311 nm) and broadband long wave (320–400 nm) radiation was added to this treatment program. For asthma, alternating magnetic therapy and low-intensity laser radiation were supplemented with hypoxic interval training.

RESULTS: Positive changes in evaluated clinical parameters were reported in all groups during the entire follow-up period. However, the presence of comorbidities reduced the therapeutic potential of the standard treatment program, according to the results of the long-term observation. The addition of dupilumab significantly improved the condition of patients with isolated rhinosinusitis with nasal polyposis. However, a history of atopic dermatitis and especially asthma reduced the duration of disease remission. The addition of physical factors to the treatment program, pathogenetically justified in the treatment of atopic dermatitis (phototherapy) and asthma (hypoxic training), reliably prolonged the remission period. Complex physiotherapy leads to long-term reduction of pathological correlations, which is manifested by decrease in weight of correlation graphs.

CONCLUSION: The main aim of the follow-up phase of the study was to evaluate the duration of the clinical result achieved, which determines the preventive potential of instrumental physiotherapy techniques, frequency and regularity of physiotherapeutic interventions. Retreatment is recommended after an average of 9–12 months for isolated rhinosinusitis with nasal polyposis and 15–18 months for atopic dermatitis and asthma.

Full Text

Restricted Access

About the authors

Larisa S. Kruglova

Central State Medical Academy of Department of Presidential Affairs

Email: kruglovals@mail.ru
ORCID iD: 0000-0002-5044-5265
SPIN-code: 1107-4372

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow

Tatyana G. Pelishenko

Clinical hospital 1 of the Department of Presidential Affairs of the Russian Federation

Email: doctor217@mail.ru
ORCID iD: 0000-0001-6597-2167
SPIN-code: 4176-8850

MD, Сand. Sci. (Medicine)

Russian Federation, Moscow

Sergey N. Nagornev

Central State Medical Academy of Department of Presidential Affairs

Author for correspondence.
Email: drnag@mail.ru
ORCID iD: 0000-0002-1190-1440
SPIN-code: 2099-3854

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow

References

  1. Shamkina PA, Krivopalov AA, Ryazantsev SV, et al. Epidemiology of chronic rhinosinusitis. Sovremennye problemy nauki i obrazovaniya. 2019;(3):188–206. EDN: SQILCY
  2. Piskunov GZ, Moiseeva YP. Polyposis rhinosinusitis. Moscow: MEDpress-Inform; 2021. 136 р. (In Russ.)
  3. Morse СJ, Miller C, Senior B. Management of chronic rhinosinusitis with nasal polyposis in the era of biologics. J Asthma Allergy. 2021;14:873–882. EDN: EVFIZJ doi: 10.2147/JAA.S258438
  4. Pelishenko TG, Kruglova LS, Nagornev SN, Frolkov VK. Comparative assessment of clinical efficacy of different methods of medical rehabilitation in patients with rhinosinusitis polyposa. Physiotherapist = Fiziotherapeutist. 2023;(4):15–24. EDN: LCAOZT doi: 10.33920/med-14-2304-02
  5. Pelishenko TG, Kruglova LS, Nagornev SN. Features of comprehensive medical rehabilitation ofpatients with polypous rhinosinusitis associated with atopic dermatitis. Russ J Environmental Rehab Med. 2023;(3):14–25. EDN: BHTZND
  6. Pelishenko TG. Complex application of therapeutic physical factors in the behaviour of medical rehabilitation of patients with polyposis rhinosinusitis associated with bronchial asthma. Russ J Environmental Rehab Med. 2023;(4):32–39. EDN: ZSEWCW
  7. Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58 (Suppl. S29):1–464. EDN: THMJZZ doi: 10.4193/Rhin20.600
  8. Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36. EDN: KNJTUD doi: 10.1016/j.jaci.2020.11.013
  9. Hanifin M, Rajka N. Diagnostic features of atopic dermatitis. Acta Dermatol Venerol. 1980;92(Suppl):44–47.
  10. Savvateeva DM, Lopatin VS. Olfactory function in patients with polyposis rhinosinusitis on the background of topical corticosteroid therapy. Rossiyskaya rinologia = Russian Rhinology. 2013;(1):24–27. EDN: TBFCJD
  11. Gorbunov SA, Rusetsky YY, Kudryashov SE, et al. Review of international questionnaires and questionnaires for assessing the quality of life in acute and chronic rhinosinusitis. Rossiyskaya rinologia = Russian Rhinology. 2021;29(2):97–106. doi: 10.17116/rosrino20212902197
  12. Braid J, Islam L, Gugiu C, et al. Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps. World Allergy Organ J. 2023;16(5):100776. EDN: CXAMWQ doi: 10.1016/j.waojou.2023.100776
  13. Dejaco D, Riedl D, Huber A, et al. The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: New clinical insights. Eur Arch Otorhinolaryngol. 2019;276(5):1355–1365. EDN: RWJBWS doi: 10.1007/s00405-019-05320-z
  14. Mullol J, Azar A, Buchheit KM, et al. Chronic rhinosinusitis with nasal polyps: Quality of life in the biologics era. J Allergy Clin Immunol Pract. 2022;10(6):1434–1453.e9. EDN: TOGQCB doi: 10.1016/j.jaip.2022.03.002
  15. Hongbo Y, Thomas CL, Harrison MA, et al. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol. 2005;125(4):659–664. doi: 10.1111/j.0022-202X.2005.23621.x
  16. Pokidysheva LI, Ignatova IA. Correlative adaptometry and the principal component method in estimation of adaptative opportunities of immune system. System Analysis Control Biomedical Systems. 2011;10(1):152–157. EDN: NDOSQZ
  17. Benkov AA, Nagornyev SN, Frolkov VK, et al. Informativity of the method of correlation adaptometry for assessing the severity of the corrective effect of combined use therapeutic physical factors on the example of metabolic syndrome. Fizioterapiya, bal’neologiya i reabilitatsiya = Russ J Physical Ther Balneother Rehabilitat. 2023;22(1):5–14. EDN: JPHBQI doi: 10.17816/rjpbr401115
  18. Danilov AA, Mikhailova AA, Edelev DA, Tyan VV. Involutive skin changes in the background metabolic syndrome-prerequisites for the development of complex physiotherapeutic influence (part 2). Russ J Environmental Rehab Med. 2023;(4):40–47. EDN: BLTJKZ
  19. Chelombitiko EG, Gusakova EV. Systemic manifestations of post-covid syndrome. Russ J Environmental Rehab Med. 2022;(3):48–60. EDN: ODNJGX
  20. Vatrella A, Fabozzi I, Calabrese C, et al. Dupilumab: A novel treatment for asthma. J Asthma Allergy. 2014;(7):123–130. doi: 10.2147/JAA.S52387
  21. Pelishenko TG, Kruglova LS, Nagornyev SN, et al. Comparative assessment of clinical efficacy of different methods of medical rehabilitation in patients with rhinosinusitis polyposa. Physiotherapist = Fiziotherapeutist. 2023;(4):15–24. EDN: LCAOZT doi: 10.33920/med-14-2304-02

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86508 от 11.12.2023
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80650 от 15.03.2021
г.